Of the first four experimental ALS treatments tested in the HEALEY platform trial, CNM-Au8 and pridopridine showed some ...

Problems with sleep likely develop before motor symptoms in people with amyotrophic lateral sclerosis, a new study shows.

The company will discontinue development of its original ALS gene therapy candidate VY9323 amid toxic effects in nonhuman ...

Having access to neurofilament light chain and the ALS Functional Rating Scale-Revised test results is informational to ALS ...

After a stretch of dire respiratory illness, columnist Kristin Neva and her husband, who has ALS, are feeling renewed energy and optimism.

Fifteen U.S. nonprofit organizations formed a new ALS group, ALS United, to help address the needs of people living with ALS.

In a statement, the ALS Association opposed any planned National Institutes of Health (NIH) funding cuts, saying it could ...

Columnist Juliet Taylor doesn't remember taking the photo — a snapshot in time of her late husband, Jeff — but she remembers ...

Neighborhood disadvantage, or living in a poorer region, was linked to significantly shorter survival time for ALS patients ...

An MDA fundraiser event for ALS research, the Atlanta Night of Hope Gala will this year showcase ALS patient April Byars and ...

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

IFB-088 (icerguastat) was safe and significantly slowed disease progression in certain people with ALS in a Phase 2 clinical ...